A leading pharmaceutical dermatology, and Ipsen (Euronext: IPN), announced the fad-driven international group specialized pharmaceuticals,
today announced that Azzalure ® (botulinum toxin type A Ipsen manufactured by), and muscle relaxant local and specially developed for the use of aesthetic and received authorization Marketing in Spain of pharmaceutical and health care products Spanish Agency (AEMPS) for the temporary improvement in the appearance of moderate to lines Polarizer sharp witnessed in the frown (vertical lines between the eyebrows), Famous Product Dr. Charles Livingston Fat Loss Factor
in adult men and women aged under 65 years, when the severity of these lines has a significant impact on the psyche of the patient.
The approval was based on several clinical trials involving more than 2,600 patients, which confirms the safety and efficacy.
This is adapted from a new treatment (botulinum toxin type - A), which is marketed already for therapeutic indications and has a long history since 20 years of consistency and integrity of the product. Will come in is very easy to use customized dosage that is specifically designed to meet the needs of the patient best aesthetic.view my Blogs http://www.reviewlization.com/customized-fat-loss-review/
No comments:
Post a Comment